IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.871
EU - Europa 28.037
AS - Asia 18.191
SA - Sud America 4.617
AF - Africa 401
OC - Oceania 111
Continente sconosciuto - Info sul continente non disponibili 109
Totale 95.337
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.481
SG - Singapore 7.573
GB - Regno Unito 7.043
RU - Federazione Russa 6.910
CN - Cina 4.691
IT - Italia 4.379
BR - Brasile 3.797
VN - Vietnam 2.317
UA - Ucraina 2.299
DE - Germania 2.195
CA - Canada 1.955
DK - Danimarca 1.526
HK - Hong Kong 1.387
SE - Svezia 797
FR - Francia 532
IE - Irlanda 530
FI - Finlandia 512
PL - Polonia 488
IN - India 352
AR - Argentina 326
MX - Messico 325
IL - Israele 265
NL - Olanda 261
BD - Bangladesh 256
TR - Turchia 237
ID - Indonesia 183
EC - Ecuador 170
JP - Giappone 162
ZA - Sudafrica 159
ES - Italia 145
PK - Pakistan 135
IQ - Iraq 128
AT - Austria 106
EU - Europa 106
AU - Australia 78
CO - Colombia 76
IR - Iran 65
KR - Corea 64
UZ - Uzbekistan 58
VE - Venezuela 58
SA - Arabia Saudita 54
MA - Marocco 53
PY - Paraguay 50
AE - Emirati Arabi Uniti 47
LT - Lituania 47
CL - Cile 45
PE - Perù 42
KE - Kenya 39
RO - Romania 38
BE - Belgio 33
NZ - Nuova Zelanda 30
EG - Egitto 29
UY - Uruguay 28
CH - Svizzera 27
SK - Slovacchia (Repubblica Slovacca) 26
TN - Tunisia 26
JO - Giordania 25
CZ - Repubblica Ceca 22
DZ - Algeria 21
AZ - Azerbaigian 20
BO - Bolivia 19
ET - Etiopia 18
CR - Costa Rica 16
TW - Taiwan 16
MY - Malesia 15
NP - Nepal 15
DO - Repubblica Dominicana 14
HN - Honduras 14
JM - Giamaica 14
KZ - Kazakistan 14
PH - Filippine 14
AM - Armenia 11
KG - Kirghizistan 11
PT - Portogallo 11
TH - Thailandia 11
BY - Bielorussia 10
NI - Nicaragua 10
TT - Trinidad e Tobago 10
AL - Albania 9
BG - Bulgaria 9
GE - Georgia 9
GR - Grecia 9
QA - Qatar 9
LV - Lettonia 8
NO - Norvegia 8
OM - Oman 8
PS - Palestinian Territory 8
SN - Senegal 8
CI - Costa d'Avorio 7
GH - Ghana 7
GT - Guatemala 7
HU - Ungheria 7
KW - Kuwait 7
PA - Panama 7
BB - Barbados 6
EE - Estonia 6
MD - Moldavia 6
MK - Macedonia 6
RS - Serbia 6
BH - Bahrain 5
Totale 95.234
Salva come PNG Salva come JPEG
Città #
Dallas 7.966
Southend 4.837
Singapore 4.037
Woodbridge 2.674
Beijing 2.330
Chandler 2.319
Ann Arbor 2.295
Houston 2.087
Ashburn 2.004
Fairfield 1.626
San Mateo 1.470
Falls Church 1.263
Hong Kong 1.187
Moscow 1.154
Jacksonville 1.095
Seattle 1.080
Dearborn 1.020
Cambridge 963
Wilmington 886
Ottawa 857
Los Angeles 843
Pisa 630
Chicago 599
Ho Chi Minh City 574
The Dalles 564
Hefei 540
Boardman 525
Stevenage 512
Dublin 506
Portsmouth 502
Dong Ket 483
Warsaw 455
New York 408
Montréal 403
São Paulo 387
Lawrence 385
Buffalo 316
Beauharnois 315
Brooklyn 302
Santa Clara 300
Hanoi 295
Munich 247
Tel Aviv 245
Rome 243
Milan 236
Salt Lake City 226
London 222
Redwood City 174
San Diego 168
Old Bridge 158
Florence 155
Montreal 136
Tokyo 133
Stockholm 132
Rio de Janeiro 131
Frankfurt am Main 130
Denver 124
Poplar 123
Istanbul 122
Chennai 118
Orem 115
Johannesburg 114
Fremont 110
Tampa 109
Phoenix 108
Atlanta 107
Mexico City 105
Elk Grove Village 104
Helsinki 100
Boston 99
Nuremberg 94
Toronto 86
Manchester 72
San Francisco 71
Haiphong 70
Amsterdam 69
Turku 69
Brasília 68
Council Bluffs 68
Belo Horizonte 67
Norwalk 67
Curitiba 65
Ankara 64
Livorno 61
Central District 60
Washington 60
Lappeenranta 58
Lucca 57
Porto Alegre 53
Tashkent 53
Biên Hòa 51
Guayaquil 51
Quito 51
Bologna 50
Da Nang 50
Campinas 49
Kansas City 49
Querétaro 49
Guangzhou 48
Shanghai 48
Totale 59.116
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.594
Value in Healthcare and the Role of the Patient Voice 1.049
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 657
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 549
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 448
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 441
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 425
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 409
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 403
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 354
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 340
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 329
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 327
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 317
Human pathophysiological adaptations to the space environment 313
La neuropatia diabetica 312
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 309
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 308
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 307
A simple echocardiographic score to rule out cardiac amyloidosis 304
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 298
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 292
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 291
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 291
Treating chemoreflex in heart failure: modulation or demolition? 291
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 288
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 288
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 285
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 284
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 283
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 283
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 281
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 278
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 277
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 277
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 276
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 276
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 274
Adrenergic activation in heart failure: blockade or rebalance? 273
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 272
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 271
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 268
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 266
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 266
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 265
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 264
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 261
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 259
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 258
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 258
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 257
Prediction of the chemoreflex gain by common clinical variables in heart failure 257
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 257
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 256
A simple echocardiographic score to rule out cardiac amyloidosis 255
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 255
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 253
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 252
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 251
[Central apneas and cardiovascular diseases] 250
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 250
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 250
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 250
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 249
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 248
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 247
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 246
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 246
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 246
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 245
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 244
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 244
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 243
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 243
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 242
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 242
Marcatori di rimodellamento e fibrosi cardiaca 242
Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation 240
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 240
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 237
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 235
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 234
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 234
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 232
How to take arms against central apneas in heart failure 232
Sex-related differences in chronic heart failure 232
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 231
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 231
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 231
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 230
Cardiac light-chain deposition disease relapsing in the transplanted heart 230
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 229
B-type natriuretic peptide secretion following scuba diving 228
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 228
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 228
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 227
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 226
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 226
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 226
Totale 29.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 508.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 508.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.328 0 0 0 0 0 1.457 917 604 630 623 744 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202629.164 2.676 8.082 5.678 6.166 5.331 1.231 0 0 0 0 0 0
Totale 95.974